Company intelligence / Profile preview

Buscar Company

Beverly Hills, California, United States

Ownership: Private
Development stage: Other

Overview

Buscar Company, through its subsidiary Armorgenix, is moving into commercial distribution of clinically evaluated detoxification and antiviral products, such as DetoxShield. Armorgenix's DetoxShield has undergone clinical evaluation and is positioned for further North American market entry, with a Texas-based manufacturing facility planned in the next 24–36 months[1].

Therapeutic areas: OtherInfectious Diseases
Modalities: Small moleculeBiologic
Industry: Biotech

Beyond the preview

Go deeper on Buscar Company.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Buscar Company.

Explore the full profile